Why AIRO's Asthma Spacer Could Change Respiratory Care Forever
Asthma affects over 300 million people worldwide. It's one of the most common chronic conditions on the planet — and yet the devices used to treat it have barely changed in decades.
That's the problem AIRO was built to solve.
The Asthma Spacer: A Device Overdue for Innovation
Spacers have been around since the 1970s. And while they work, they're far from perfect.
The core issues with traditional spacers are well-documented:
- Poor drug delivery efficiency — a significant portion of medication never reaches the lungs
- Low patient compliance — bulky, inconvenient designs mean people simply don't use them consistently
- Outdated materials and design — most spacers look and function almost identically to those made 40 years ago
- Limited feedback — patients have no way of knowing whether they're using the device correctly
What Makes AIRO Different
AIRO's next-generation asthma spacer is designed from the ground up to address every one of these shortcomings. Our device focuses on three core improvements: enhanced drug delivery through improved aerosol dynamics and chamber geometry; patient-centred design that is compact, intuitive, and genuinely easy to use; and real-world usability built for daily life — durable, easy to clean, and designed to integrate seamlessly.
The Market Opportunity
The global asthma treatment market is worth over $20 billion and growing. Despite the size of the market, innovation has been slow. That's left a clear gap — and AIRO is positioned to fill it.
Why Now?
Rising asthma prevalence, increased focus on respiratory health post-pandemic, clearer regulatory pathways, and an early-stage investment opportunity all converge to make this the right moment for AIRO.
Join Us
AIRO's GoFundMe campaign is now open. Ready to be part of the solution? Back AIRO on GoFundMe and help us change respiratory care forever.